Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Capitol Capsule: Poor image, branding problems harm US FDA's ability to attract top scientists

This article was originally published in Scrip

Executive Summary

With the potential the US FDA’s budget could be slashed by 8.2%, or about $318 million, if the across-the-board sequestration funding cuts kick in come January – something President Barack Obama insists will not happen – and its public image again in shambles after failing to take action to prevent the current meningitis calamity caused by compounded drugs, the agency’s prospects for winning top talent probably are not the best right now.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts